DGAP-News: Press Release: 4SC to present at two upcoming investor conferences

DGAP-News: 4SC AG / Key word(s): Miscellaneous
Press Release: 4SC to present at two upcoming investor conferences

12.04.2013 / 08:44

---------------------------------------------------------------------

Press Release

4SC to present at two upcoming investor conferences

- BioCapital Europe Conference (17 April 2013, Amsterdam)

- Kempen & Co. Healthcare & Life Sciences Conference (23 April 2013,
Amsterdam)

Planegg-Martinsried/Germany, 12 April 2013 - 4SC AG (Frankfurt, Prime
Standard: VSC), a discovery and development company of targeted small
molecule drugs for cancer and autoimmune diseases, will be presenting at
two upcoming investor conferences.

Enno Spillner, Chief Executive Officer & Chief Financial Officer of 4SC AG,
will give a company presentation at the BioCapital Europe conference, which
will be held on 17 April 2013 in Amsterdam/The Netherlands. The
presentation of 4SC will begin at 3.20pm (CEST).

Enno Spillner will also present 4SC to investors at the Kempen & Co.
Healthcare & Life Sciences Conference, which will be held on 23 April 2013
in Amsterdam.

Ends

About 4SC

The Group managed by 4SC AG (ISIN DE0005753818) discovers and develops
targeted, small-molecule drugs for treating diseases with high unmet
medical needs in various autoimmune and cancer indications. These drugs are
intended to provide innovative treatment options that are more tolerable
and efficacious than existing therapies, and provide a better quality of
life. The Company's balanced pipeline comprises promising products that are
in various stages of clinical development. 4SC's aim is to generate future
growth and enhance its enterprise value by entering into partnerships with
leading pharmaceutical companies. Founded in 1997, 4SC had 86 employees at
the end of 2012. 4SC AG has been listed on the Prime Standard of the
Frankfurt Stock Exchange since December 2005.

Legal Note

This document may contain projections or estimates relating to plans and
objectives relating to our future operations, products, or services; future
financial results; or assumptions underlying or relating to any such
statements; each of which constitutes a forward-looking statement subject
to risks and uncertainties, many of which are beyond our control. Actual
results could differ materially, depending on a number of factors.

For more information please visit www.4sc.com or contact:

4SC AG
Jochen Orlowski, Corporate Communications & Investor Relations
jochen.orlowski(at)4sc.com, Tel.: +49-89-7007-63-66

MC Services
Mareike Mohr, Raimund Gabriel
mareike.mohr(at)mc-services.eu , Tel.: +49-89-2102-28-40
raimund.gabriel(at)mc-services.eu , Tel.: +49-89-2102-28-30

The Trout Group
Chad Rubin
Crubin(at)troutgroup.com, Tel.: +1-646-378-2947

End of Corporate News

---------------------------------------------------------------------

12.04.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------

Language: English
Company: 4SC AG
Am Klopferspitz 19a
82152 Martinsried
Germany
Phone: +49 (0)89 7007 63-0
Fax: +49 (0)89 7007 63-29
E-mail: public@4sc.com
Internet: www.4sc.de
ISIN: DE0005753818
WKN: 575381
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, München, Stuttgart

End of News DGAP News-Service
---------------------------------------------------------------------
206905 12.04.2013